Document Type
Article
Publication Date
2026
DOI
10.1002/alr.70144
Publication Title
International Forum of Allergy & Rhinology
Volume
16
Issue
4
Pages
429-431
Abstract
[Introduction] Borish et al. provided an excellent review highlighting methodological variability among the six pivotal Phase III trials [1]. One critical yet overlooked issue is the inconsistent application of the endoscopic nasal polyp score (NPS), a primary outcome measure in all trials.
Rights
© 2026 The Authors
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Original Publication Citation
Sowerby, L. J., Pourmomenarabi, B., Maniaci, A., Ginty, O., & Han, J. K. (2026). Revisiting nasal polyp scoring in clinical trials: Interpretive variability and the need for standardization. International Forum of Allergy & Rhinology, 16(4), 429-431. https://doi.org/10.1002/alr.70144
Repository Citation
Sowerby, L. J., Pourmomenarabi, B., Maniaci, A., Ginty, O., & Han, J. K. (2026). Revisiting nasal polyp scoring in clinical trials: Interpretive variability and the need for standardization. International Forum of Allergy & Rhinology, 16(4), 429-431. https://doi.org/10.1002/alr.70144